A detailed history of Scientech Research LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Scientech Research LLC holds 17,671 shares of BEAM stock, worth $509,101. This represents 0.09% of its overall portfolio holdings.

Number of Shares
17,671
Previous 51,876 65.94%
Holding current value
$509,101
Previous $1.22 Billion 64.38%
% of portfolio
0.09%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.57 - $33.14 $772,006 - $1.13 Million
-34,205 Reduced 65.94%
17,671 $433 Million
Q2 2024

Aug 14, 2024

BUY
$21.22 - $32.66 $688,992 - $1.06 Million
32,469 Added 167.31%
51,876 $1.22 Billion
Q1 2024

May 15, 2024

BUY
$23.46 - $45.07 $255,127 - $490,136
10,875 Added 127.46%
19,407 $641 Million
Q4 2023

Feb 14, 2024

BUY
$17.69 - $30.76 $150,931 - $262,444
8,532 New
8,532 $232 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.03B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.